Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus

Infection and Drug Resistance

Volumn 6, Issue , 2013, Pages 175-186

  Antonic, Vlado ^a,b,c   Stojadinovic, Alexander ^c,d,e   Zhang, Binxue ^a,b,c   Izadjoo, Mina J ^a,b,c,e   Alavi, Mohammad ^a,b,c  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b Advancement of Military Medicine   (United States)

^c Walter Reed National Military Medical Center ^*

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Catalase; Interspecies interaction; Pseudomonas aeruginosa; Staphylococcus aureus; Staphyloxanthin

Indexed keywords

CATALASE; HYDROGEN PEROXIDE; POLYMYXIN B; STAPHYLOXANTHIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CATALASE GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRTM GENE; FARNESYL PYROPHOSPHATE SYNTHASE GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HFQ GENE; INTERSPECIFIC RELATIONSHIP; MACROPHAGE; MIXED INFECTION; NONHUMAN; OPERON; PHENOTYPE; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SARA GENE; SIGB GENE; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION; UPREGULATION; WOUND INFECTION;

EID: 84887181328     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: 10.2147/IDR.S49039     Document Type: Article

References (48)

1. Lennette EH, Balows A, Hausler WJ Jr, Shadomy JH. Manual of Clinical Microbiology. 4th ed. Washington, DC: American Society for Microbiology; 1985.
2. Rosenbach AJ. [Mikro-Qrganismen bei den Wund Infections Krankheiten des Menschen]. Wiesbaden: JF Bergmann; 1884. German.
3. Rosenfeld M, Ramsey BW, Gibson RL. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med. 2003;9(6):492-497.
4. McDougall KE, Perry MJ, Gibson RL, Colley SM, Korach KS, Tobias JH. Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice. Endocrinology. 2003;144(5):1994-1999.
5. Bartowsky EJ, Xia D, Gibson RL, Fleet GH, Henschke PA. Spoilage of bottled red wine by acetic acid bacteria. Lett Appl Microbiol. 2003; 36(5): 307-314.
6. Mashburn KL, Atkinson S. Evaluation of adrenal function in serum and feces of Steller sea lions (Eumetopias jubatus): influences of molt, gender, sample storage, and age on glucocorticoid metabolism. Gen Comp Endocrinol. 2004;136(3):371-381.
7. Holt DC, Holden MT, Tong SY, etal. A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol. 2011;3:881-895.
8. Marshall JH, Wilmoth GJ. Proposed pathway of triterpenoid carotenoid biosynthesis in Staphylococcus aureus: evidence from a study of mutants. J Bacteriol. 1981;147(3):914-919.
9. Marshall JH, Wilmoth GJ. Pigments of Staphylococcus aureus, a series of triterpenoid carotenoids. J Bacteriol. 1981;147(3):900-913.
10. Pelz A, Wieland KP, Putzbach K, Hentschel P, Albert K, Gotz F. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J Biol Chem. 2005;280(37):32493-32498.
11. Wieland B, Feil C, Gloria-Maercker E, etal. Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4′-diaponeurosporene of Staphylococcus aureus. J Bacteriol. 1994;176(24):7719-7726.
12. Clauditz A, Resch A, Wieland KP, Peschel A, Gotz F. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun. 2006;74(8):4950-4953.
13. Liu GY, Essex A, Buchanan JT, etal. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med. 2005;202(2):209-215.
14. Popov Iu A, Kaprel'iants AS, Ostrovskii DN, Ignatov VV. Study of the membranes of pigment-free mutant of Staphylococcus aureus. Biokhimiia. 1976;41(6):1116-1120. Russian.
15. Mishra NN, Liu GY, Yeaman MR, etal. Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob Agents Chemother. 2011;55(2): 526-531.
16. Liu CI, Liu GY, Song Y, etal. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science. 2008;319(5868): 1391-1394.
17. Song Y, Liu CI, Lin FY, etal. Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results. J Med Chem. 2009;52(13):3869-3880.
18. Valencia IC, Kirsner RS, Kerdel FA. Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period. J Am Acad Dermatol. 2004;50(6):845-849.
19. Brook I, Frazier EH. Aerobic and anaerobic microbiology of chronic venous ulcers. Int J Dermatol. 1998;37(6):426-428.
20. Mousa HA. Aerobic, anaerobic and fungal burn wound infections. J Hosp Infect. 1997;37(4):317-323.
21. Summanen PH, Talan DA, Strong C, etal. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20 Suppl 2:S279-S282.
22. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14(2):244-269.
23. Brogden KA, Guthmiller JM, Taylor CE. Human polymicrobial infections. Lancet. 2005;365(9455):253-255.
24. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology. 2007;153(Pt 4):917-923.
25. Hoffman LR, Deziel E, D'Argenio DA, etal. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2006;103(52): 19890-19895.
26. Korgaonkar A, Trivedi U, Rumbaugh KP, Whiteley M. Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc Natl Acad Sci U S A. 2013;110(3):1059-1064.
27. Biswas L, Biswas R, Schlag M, Bertram R, Gotz F. Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol. 2009;75(21):6910-6912.
28. Mitchell G, Seguin DL, Asselin AE, etal. Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC Microbiology. 2010;10:33.
29. Lightbown JW, Jackson FL. Inhibition of cytochrome systems of heart muscle and certain bacteria by the antagonists of dihydrostreptomycin: 2-alkyl-4-hydroxyquinoline N-oxides. Biochem J. 1956;63(1):130-137.
30. Machan ZA, Pitt TL, White W, etal. Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance. J Med Microbiol. 1991;34(4):213-217.
31. Lightbown JW, Jackson FL. Inhibition of cytochrome system of heart muscle and of Staphylococcus aureus by 2-heptyl-4-hydroxyquinoline-N-oxide, an antagonist of dihydrostreptomycin. Biochem J. 1954;58(4):xlix.
32. Hendricks KJ, Burd TA, Anglen JO, Simpson AW, Christensen GD, Gainor BJ. Synergy between Staphylococcus aureus and Pseudomonas aeruginosa in a rat model of complex orthopaedic wounds. J Bone Joint Surg Am. 2001;83-A(6):855-861.
33. Marchesi JR, Sato T, Weightman AJ, etal. Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. Appl Environ Microbiol. 1998;64(2):795-799.
34. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
35. Morikawa K, Maruyama A, Inose Y, Higashide M, Hayashi H, Ohta T. Overexpression of sigma factor, sigma(B), urges Staphylococcus aureus to thicken the cell wall and to resist beta-lactams. Biochem Biophys Res Commun. 2001;288(2):385-389.
36. Song Y, Lin FY, Yin F, etal. Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus. J Med Chem. 2009;52(4):976-988.
37. Williamson NR, Fineran PC, Leeper FJ, Salmond GP. The biosynthesis and regulation of bacterial prodiginines. Nat Rev Microbiol. 2006;4(12):887-899.
38. McClean KH, Winson MK, Fish L, etal. Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology. 1997;143(Pt 12):3703-3711.
39. Thomson NR, Crow MA, McGowan SJ, Cox A, Salmond GP. Biosynthesis of carbapenem antibiotic and prodigiosin pigment in Serratia is under quorum sensing control. Mol Microbiol. 2000;36(3): 539-556.
40. Fey PD, Endres JL, Yajjala VK, etal. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. MBio. 2013;4:e00537-12.
41. Castro SL, Nelman-Gonzalez M, Nickerson CA, Ott CM. Induction of attachment-independent biofilm formation and repression of Hfq expression by low-fluid-shear culture of Staphylococcus aureus. Appl Environ Microbiol. 2011;77:6368-6378.
42. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun. 1993;61(9): 3879-3885.
43. Queck SY, Jameson-Lee M, Villaruz AE, etal. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell. 2008;32:150-158.
44. Kanafani H, Martin SE. Catalase and superoxide dismutase activities in virulent and nonvirulent Staphylococcus aureus isolates. J Clin Microbiol. 1985;21:607-610.
45. Deguchi K, Yokota N, Koguchi M, etal. Antimicrobial activities of polymyxin B against clinically isolated microbial strains. Results of MIC determination including high concentrations. Jpn J Antibiot. 1993;46(10):884-895. Japanese.
46. Vyas R, Gao GY, Harden JD, Zhang XP. Iron(III) porphyrin catalyzed aziridination of alkenes with bromamine-T as nitrene source. Org Lett. 2004;6(12):1907-1910.
47. Liu Y, Wu N, Dong J, etal. Hfq is a global regulator that controls the pathogenicity of Staphylococcus aureus. PloS One. 2010;5(9):1-9.
48. Leejae S, Hasap L, Voravuthikunchai SP. Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a new antibiotic candidate. J Med Microbiol. 2013;62(Pt 3):421-428.